TickerFactsScreenerDevelopers

Coherus Oncology, Inc. (CHRS) — Revenue

Annual figures by fiscal year, from SEC filings.

2016: $189.48M2017: $1.56M2018: $02019: $356.07M2020: $475.82M2021: $326.55M2022: $211.04M2023: $257.24M2024: $26.39M2025: $42.17M$42.17M
2016Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$42.17M+59.8%
2024$26.39M-89.7%
2023$257.24M+21.9%
2022$211.04M-35.4%
2021$326.55M-31.4%
2020$475.82M+33.6%
2019$356.07M—
2018$0-100.0%
2017$1.56M-99.2%
2016$189.48M—